SCHEMBL29643881

SCHEMBL29643881

Cc1cc2c(Br)c[nH]c2nc1C#N

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.34
▸ CHUK O15111 1/20 0.31
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27140774 1.00 AXL (0.34) AXLCHUKMAPK1
SCHEMBL29643720 0.69 CHUK (0.41) CHUK
SCHEMBL27149746 0.69 CHUK (0.41) CHUK
SCHEMBL30204138 0.68 AXL (0.44) AXLCHUKMAPK1
SCHEMBL21178475 0.68 AXL (0.44) AXLCHUKMAPK1
SCHEMBL24005847 0.68 RIPK1 (0.43) AXL
SCHEMBL26096528 0.68 CHUK (0.43) CHUK
SCHEMBL19932698 0.66 CHUK (0.38) CHUK
SCHEMBL19932697 0.66 CHUK (0.38) CHUK
SCHEMBL14635390 0.65 ADORA2A (0.50) AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4255904-A2 NOVEL PAR-2 INHIBITORS Domain Therapeutics (FR) 2023-10-11 — — EP disclosed
WO-2022117882-A2 NOVEL PAR-2 INHIBITORS DOMAIN THERAPEUTICS (FR) 2022-06-09 — — WO disclosed
Send feedback